NM_005609.4:c.13_14delCT
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005609.4(PYGM):c.13_14delCT(p.Leu5ValfsTer22) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005609.4 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYGM | ENST00000164139.4 | c.13_14delCT | p.Leu5ValfsTer22 | frameshift_variant | Exon 1 of 20 | 1 | NM_005609.4 | ENSP00000164139.3 | ||
PYGM | ENST00000377432.7 | c.13_14delCT | p.Leu5ValfsTer22 | frameshift_variant | Exon 1 of 18 | 2 | ENSP00000366650.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251176Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135810
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461764Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 727176
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74492
ClinVar
Submissions by phenotype
Glycogen storage disease, type V Pathogenic:3
Variant summary: PYGM c.13_14delCT (p.Leu5ValfsX22) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 4e-06 in 251176 control chromosomes. c.13_14delCT has been reported in the literature in compound heterozygous and homozygous individuals affected with Glycogen Storage Disease, Type V (Rubio_2006, Snchez-Tejerina_2021). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17172620, 33837115). ClinVar contains an entry for this variant (Variation ID: 371064). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 17172620). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 371064). This variant is present in population databases (rs772194378, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Leu5Valfs*22) in the PYGM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PYGM are known to be pathogenic (PMID: 8316268, 16786513). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at